PK analyses
In TED-C14-004, data for PK analyses were available for 8 patients (72.7%); teduglutide was undetectable in the plasma of the other 3 patients at all time points, most likely because of dosing errors (improved training of patients or caregivers to administer teduglutide was then implemented in SHP633-306 and SHP633-307). PK analyses of teduglutide showed that a CPatients in SHP633-307 from TED-C14-004 achieved a C